IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 231 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $450 | +25.3% | 58,789 | +87.5% | 0.01% | -41.2% |
| Q4 2023 | $359 | -8.7% | 31,352 | -23.2% | 0.02% | +6.2% |
| Q3 2023 | $393 | -10.9% | 40,830 | -1.5% | 0.02% | -5.9% |
| Q2 2023 | $441 | +0.5% | 41,463 | -0.6% | 0.02% | -5.6% |
| Q1 2023 | $439 | -15.3% | 41,697 | -0.3% | 0.02% | -21.7% |
| Q4 2022 | $518 | -99.9% | 41,841 | -17.4% | 0.02% | +15.0% |
| Q3 2022 | $525,000 | -28.8% | 50,679 | -20.8% | 0.02% | -9.1% |
| Q2 2022 | $737,000 | -8.2% | 63,959 | +0.2% | 0.02% | +15.8% |
| Q1 2022 | $803,000 | -6.1% | 63,850 | -12.9% | 0.02% | +5.6% |
| Q4 2021 | $855,000 | -10.3% | 73,295 | +0.5% | 0.02% | -14.3% |
| Q3 2021 | $953,000 | -2.7% | 72,957 | -4.1% | 0.02% | +10.5% |
| Q2 2021 | $979,000 | +60.5% | 76,087 | +39.5% | 0.02% | +58.3% |
| Q1 2021 | $610,000 | +139.2% | 54,539 | +143.2% | 0.01% | +140.0% |
| Q4 2020 | $255,000 | +26.2% | 22,427 | 0.0% | 0.01% | 0.0% |
| Q3 2020 | $202,000 | -12.6% | 22,427 | 0.0% | 0.01% | -16.7% |
| Q2 2020 | $231,000 | +102.6% | 22,427 | +99.0% | 0.01% | +100.0% |
| Q1 2020 | $114,000 | -25.0% | 11,270 | -1.5% | 0.00% | 0.0% |
| Q4 2019 | $152,000 | +50.5% | 11,442 | -2.4% | 0.00% | +50.0% |
| Q3 2019 | $101,000 | -21.7% | 11,723 | -0.9% | 0.00% | -33.3% |
| Q2 2019 | $129,000 | -21.3% | 11,824 | -2.2% | 0.00% | -25.0% |
| Q1 2019 | $164,000 | +31.2% | 12,094 | 0.0% | 0.00% | +33.3% |
| Q4 2018 | $125,000 | -48.3% | 12,094 | -7.6% | 0.00% | -40.0% |
| Q3 2018 | $242,000 | -3.2% | 13,094 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $250,000 | +17.4% | 13,094 | -5.3% | 0.01% | +25.0% |
| Q1 2018 | $213,000 | +2.9% | 13,833 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $207,000 | – | 13,833 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $183,240,000 | 17.56% |
| HealthInvest Partners AB | 1,450,000 | $16,211,000 | 12.91% |
| Healthcare Value Capital, LLC | 200,000 | $2,236,000 | 4.98% |
| BRIDGER MANAGEMENT, LLC | 2,852,414 | $31,890,000 | 2.98% |
| Camber Capital Management LP | 7,500,000 | $83,850,000 | 2.88% |
| 13D Management LLC | 658,017 | $7,357,000 | 2.72% |
| Brown Capital Management | 20,170,126 | $225,502,000 | 1.68% |
| Healthcare Value Capital, LLC | 50,000 | $559,000 | 1.24% |
| Zebra Capital Management LLC | 59,122 | $661,000 | 0.73% |
| PRICE MICHAEL F | 520,000 | $5,814,000 | 0.70% |